Paul Calabresi: A founder and giant in the field of medical oncology

Share on facebook
Share on twitter
Share on linkedin
Share on email
Share on print
Celia and Paul Calabresi at the Matterhorn

The story of modern cancer therapy would not be complete without the inclusion of the work of Paul Calabresi and some insights about the challenges he faced, along with his accomplishments.

For this chapter in the Cancer History Project, I revised and extended a Memorial I wrote for Paul in 2006. I also had the pleasure of interviewing many who knew him well including his children: Steven Calabresi, Janice Calabresi Maggs and Peter A. Calabresi, MD. Others gave generously of their time to speak with me and share stories and experiences which I hope will add some richness to Paul’s contributions as an oncologist.

Fred Schiffman, MD, MACP
Sigal Family Professor of Humanistic Medicine;
Vice Chairman of Medicine, Warren Alpert Medical School of Brown University; Medical Director of the Lifespan Cancer Institute; Associate Physician-in-Chief, The Miriam Hospital
Table of Contents

YOU MAY BE INTERESTED IN

More than half of deaths that are not attributed to disease progression or recurrence after CAR T-cell therapy are caused by infections—an unprecedented finding that experts say marks a shift from a conventional focus on mitigating treatment-specific adverse events to including prevention and management of infections.
Fred Schiffman, MD, MACP
Sigal Family Professor of Humanistic Medicine;
Vice Chairman of Medicine, Warren Alpert Medical School of Brown University; Medical Director of the Lifespan Cancer Institute; Associate Physician-in-Chief, The Miriam Hospital

Login